Effectiveness of Injectable Ibuprofen Salts and Indomethacin to Treat Patent Ductus Arteriosus in Preterm Infants: Observational Cohort Study.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Canadian Journal of Hospital Pharmacy

• Publication date

  2018-03-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.4212/CJHP.V71I1.1725PMID 29531394PMCID PMC5842047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary hemorrhage in very low birth weight infants: a case-control analysis.

  2015cited by this paper
• Association between Hemodynamically Significant Patent Ductus Arteriosus and Bronchopulmonary Dysplasia.

  2015cited by this paper
• Chorioamnionitis and Patent Ductus Arteriosus: A Systematic Review and Meta-Analysis

  2015cited by this paper
• Effectiveness and Safety of Indomethacin versus Ibuprofen for the Treatment of Patent Ductus Arteriosus in Preterm Infants

  2013cited by this paper
• High‐Dose Ibuprofen for Patent Ductus Arteriosus in Extremely Preterm Infants: A Randomized Controlled Study

  2012cited by this paper
• Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

  2010cited by this paper
• Patent Ductus Arteriosus of the Preterm Infant

  2010cited by this paper
• Etiology and outcome of acute kidney injury in children

  2010cited by this paper
• Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects.

  2009cited by this paper
• Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall.

  2009cited by this paper
• Failure of Ductus Arteriosus Closure Is Associated With Increased Mortality in Preterm Infants

  2009cited by this paper
• Ibuprofen Versus Continuous Indomethacin in Premature Neonates With Patent Ductus Arteriosus: Is the Difference in the Mode of Administration?

  2008cited by this paper
• Prevalence of Spontaneous Closure of the Ductus Arteriosus in Neonates at a Birth Weight of 1000 Grams or Less

  2006cited by this paper
• Prophylactic Ibuprofen Versus Placebo in Very Premature Infants: A Randomised, Double-Blind, Placebo-Controlled Trial

  2006cited by this paper
• Dose‐finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method

  2005cited by this paper
• Patent Ductus Arteriosus, Indomethacin and Necrotizing Enterocolitis in Very Low Birth Weight Infants: A Population-Based Study

  2005cited by this paper
• Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

  2005cited by this paper
• Combined Treatment With a Nonselective Nitric Oxide Synthase Inhibitor (L-NMMA) and Indomethacin Increases Ductus Constriction in Extremely Premature Newborns

  2005cited by this paper
• Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial.

  2004cited by this paper
• Patency of the preterm fetal ductus arteriosus is regulated by endothelial nitric oxide synthase and is independent of vasa vasorum in the mouse.

  2004cited by this paper
• Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants

  2003cited by this paper
• Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial

  2002cited by this paper
• A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.

  2000cited by this paper
• Ibuprofen and patent ductus arteriosus.

  2000cited by this paper
• The Role of Nitric Oxide in Dilating the Fetal Ductus Arteriosus in Rats

  1999cited by this paper
• Cerebral blood flow velocity and pulsation in neonatal respiratory distress syndrome and periventricular hemorrhage.

  1997cited by this paper
• Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus.

  1997cited by this paper
• Treatment of patent ductus arteriosus with ibuprofen

  1997cited by this paper
• INTRAVENOUS IBUPROFEN (IBU) FOR THE TREATMENT OF PATENT DUCTUS ARTERIOSUS(PDA) IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME (RDS). † 1486

  1996cited by this paper
• Necrotizing Enterocolitis: Treatment Based on Staging Criteria

  1986cited by this paper
• Medical management of small preterm infants with symptomatic patent ductus arteriosus.

  1978cited by this paper

• Effectiveness of Ibuprofen Arginine, Ibuprofen Lysine, and Indomethacin for Patent Ductus Arteriosus Closure in Neonates.

  2026cites this paper
• Combination therapy for patent ductus arteriosus in preterm infants: Echocardiographic changes and clinical use

  2023cites this paper
• Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)

  2021cites this paper
• Patent Ductus Arteriosus-Time for a Definitive Trial.

  2020cites this paper
• Efficacy and safety of pharmacological treatments for Patent Ductus Arteriosus closure: a systematic review and network meta-analysis of clinical trials and observational studies.

  2019cites this paper